Financials Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Market Closed - Nyse 01:30:01 03/05/2024 am IST 5-day change 1st Jan Change
79.28 USD -0.25% Intraday chart for Globe Life Inc. +4.95% -34.87%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 11,397 9,939 9,464 11,726 11,456 7,455 - -
Enterprise Value (EV) 1 13,045 11,862 11,490 13,803 13,572 10,185 10,676 11,189
P/E ratio 15.4 x 13.9 x 13 x 16.1 x 12.1 x 6.89 x 6.2 x 5.61 x
Yield 0.66% 0.79% 0.84% 0.69% 0.74% 1.14% 1.14% 1.08%
Capitalization / Revenue 2.52 x 2.1 x 1.85 x 2.25 x 2.1 x 1.28 x 1.22 x 1.17 x
EV / Revenue 2.88 x 2.5 x 2.25 x 2.65 x 2.49 x 1.75 x 1.75 x 1.75 x
EV / EBITDA 12.6 x 11.9 x 11.3 x - - 6.83 x 7.11 x 7.19 x
EV / FCF - - - - - 22.6 x - -
FCF Yield - - - - - 4.42% - -
Price to Book 1.59 x 1.14 x 1.09 x 2.43 x 2.58 x 1.31 x 1.11 x 0.91 x
Nbr of stocks (in thousands) 1,08,288 1,04,662 1,00,979 97,270 94,119 94,037 - -
Reference price 2 105.2 94.96 93.72 120.6 121.7 79.28 79.28 79.28
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,528 4,738 5,113 5,215 5,448 5,825 6,088 6,377
EBITDA 1 1,032 1,000 1,016 - - 1,491 1,501 1,556
EBIT 1 - 706.7 666.3 799.4 1,279 1,387 1,444 -
Operating Margin - 14.92% 13.03% 15.33% 23.47% 23.81% 23.72% -
Earnings before Tax (EBT) 1 - - - - 1,194 1,328 1,441 1,537
Net income 1 760.8 731.8 745 739.7 970.8 1,076 1,145 1,217
Net margin 16.8% 15.45% 14.57% 14.18% 17.82% 18.47% 18.8% 19.08%
EPS 2 6.830 6.820 7.220 7.470 10.07 11.50 12.79 14.13
Free Cash Flow 1 - - - - - 450 - -
FCF margin - - - - - 7.73% - -
FCF Conversion (EBITDA) - - - - - 30.18% - -
FCF Conversion (Net income) - - - - - 41.83% - -
Dividend per Share 2 0.6900 0.7500 0.7900 0.8300 0.9000 0.9000 0.9075 0.8550
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,278 1,297 1,308 1,293 1,291 1,323 1,321 1,326 1,384 1,416 1,416 1,449 1,465 1,481 1,506
EBITDA - - - - - - - - - - - - - - -
EBIT 1 173.4 159.4 159.3 206 215.8 218.4 311 315.4 324.3 327.8 324.4 346.1 350.4 352.1 340.2
Operating Margin 13.57% 12.29% 12.17% 15.93% 16.71% 16.51% 23.54% 23.78% 23.43% 23.16% 22.9% 23.88% 23.92% 23.78% 22.59%
Earnings before Tax (EBT) 1 - 217.6 201.6 217 230 257.7 274.2 264.5 318.8 336.7 314.9 339 345.3 350.2 352.2
Net income 1 - 178 164.4 177 186.8 211.6 223.6 215.3 257.1 274.8 254.2 270.1 273.4 277.6 281.2
Net margin - 13.72% 12.56% 13.69% 14.46% 15.99% 16.92% 16.23% 18.57% 19.41% 17.95% 18.64% 18.66% 18.75% 18.67%
EPS 2 1.840 1.760 1.640 1.790 1.900 2.140 2.280 2.240 2.680 2.880 2.670 2.864 2.950 3.022 3.067
Dividend per Share 2 0.1975 0.1975 0.2075 0.2075 0.2075 0.2075 0.2250 0.2250 0.2250 0.2250 0.2367 0.2400 0.2400 0.2400 -
Announcement Date 20/10/21 02/02/22 20/04/22 27/07/22 26/10/22 01/02/23 03/05/23 26/07/23 25/10/23 07/02/24 22/04/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,648 1,923 2,026 2,077 2,116 2,729 3,221 3,734
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.597 x 1.922 x 1.994 x - - 1.83 x 2.146 x 2.399 x
Free Cash Flow 1 - - - - - 450 - -
ROE (net income / shareholders' equity) 11.6% 9.5% 8.13% 10.9% 24.3% 21.7% 19.1% 15.4%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 66.00 83.20 86.00 49.70 47.10 60.70 71.60 87.10
Cash Flow per Share - 13.80 13.90 14.40 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 04/02/20 02/02/21 02/02/22 01/02/23 07/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
79.28 USD
Average target price
106.4 USD
Spread / Average Target
+34.26%
Consensus
  1. Stock Market
  2. Equities
  3. GL Stock
  4. Financials Globe Life Inc.